1. Home
  2. AXS vs STVN Comparison

AXS vs STVN Comparison

Compare AXS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axis Capital Holdings Limited

AXS

Axis Capital Holdings Limited

HOLD

Current Price

$103.96

Market Cap

7.4B

Sector

Finance

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$20.96

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXS
STVN
Founded
2001
1949
Country
Bermuda
Italy
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AXS
STVN
Price
$103.96
$20.96
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$115.00
$25.38
AVG Volume (30 Days)
609.7K
338.7K
Earning Date
01-28-2026
11-06-2025
Dividend Yield
1.69%
0.30%
EPS Growth
68.27
19.61
EPS
12.10
0.60
Revenue
$6,301,015,000.00
$1,373,219,524.00
Revenue This Year
$6.62
$8.42
Revenue Next Year
$8.64
$9.52
P/E Ratio
$8.62
$34.83
Revenue Growth
5.59
6.97
52 Week Low
$83.90
$17.81
52 Week High
$107.19
$28.00

Technical Indicators

Market Signals
Indicator
AXS
STVN
Relative Strength Index (RSI) 65.59 39.09
Support Level $97.16 $20.62
Resistance Level $102.58 $23.88
Average True Range (ATR) 1.93 1.14
MACD 0.10 -0.08
Stochastic Oscillator 96.94 10.68

Price Performance

Historical Comparison
AXS
STVN

About AXS Axis Capital Holdings Limited

Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: